Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Novartis Investigative Site, Vienna

Novartis Investigative Site, Uijeongbu-si

Novartis Investigative Site, Milan

Sidney Kimmel Comprehensive Cancer Center, Baltimore

Novartis Investigative Site, Madrid

Georgia Regents University, Augusta

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Taoyuan District

Novartis Investigative Site, Seville

Novartis Investigative Site, Valencia

Novartis Investigative Site, Changhua

Novartis Investigative Site, Moscow

Novartis Investigative Site, Moscow

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Montreal

Novartis Investigative Site, Brno

Novartis Investigative Site, Copenhagen

Novartis Investigative Site, Dresden

Novartis Investigative Site, Roma

Novartis Investigative Site, Krakow

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Wroclaw

Novartis Investigative Site, Lisbon

Novartis Investigative Site, Porto

Novartis Investigative Site, Seoul

Novartis Investigative Site, Badalona

Novartis Investigative Site, Liverpool

Novartis Investigative Site, London

Novartis Investigative Site, Oxford